Story Poster
Photo by Scott Clause//USA TODAY Network
LSU Baseball

LSU's Ethan Frey selected No., 95 overall by the Astros

July 13, 2025
226

BATON ROUGE, La. – LSU outfielder/designated hitter Ethan Frey was selected No. 95 overall Sunday night in the third round of the MLB Draft by the Houston Astros.

 

Rounds 1-3 of the draft are being conducted Sunday evening in Atlanta. Rounds 4-20 will be held starting at 10:30 a.m. CT Monday, and the draft may be viewed at MLB.com.

 

Frey was the fourth LSU player selected on Sunday, joining left-hander Kade Anderson (1st round, No. 3) by the Seattle Mariners; right-hander Chase Shores (2nd round, No. 47) by the Los Angeles Angels; and right-hander Anthony Eyanson (3rd round, No. 87) by the Boston Red Sox.

 

Frey, a junior from Rosepine, La., batted .331 this season with 15 doubles, one triple, 13 homers, 50 RBI and 43 runs. He scored a team-high six runs in the 2025 College World Series, posted a .391 on-base percentage in the CWS that included two doubles and four walks.

 

Frey delivered an RBI double for LSU’s first run in Game 2 of the College World Series Finals versus Coastal Carolina, as the Tigers went on to a 5-3 victory to claim the NCAA National Championship.

 

He was voted to the NCAA Baton Rouge Regional All-Tournament Team, batting .375 (6-for-16) with three doubles, one triple, one homer, six RBI and five runs.

 

In the Tigers’ NCAA Regional championship game win over Little Rock, Frey was 4-for-4 with two doubles, one homer, four RBI, two walks and two runs scored

 

Frey batted .400 (4-for-10) in LSU’s SEC regular-season series versus Arkansas with one double, two homers, six RBI and four runs. He provided a walk-off sacrifice fly in the bottom of the 10th inning to lift LSU to a win in Game 1 of the series, and he blasted a three-run homer in Game 2 while driving in four runs.

Tags: Baseball
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.